Ambikahc Tablet 5/20/12.5mg
Olmesartan Medoxomil 20mg · Amlodipine Besylate 6.944mg +1 more
Tablet · Prescription medication · Combination
Aprogen Biologics Co., Ltd.
MFDS item code 201905668 · Approved 2019.08.12
This product's status changed to Expired on 2024.08.12. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Improved blood pressure control for essential hypertension
The combination therapy of Amlodipine and Olmesartan Medoxomil is used when patients with essential hypertension have difficulty controlling their blood pressure. These two components act together to expand blood vessels and lower blood pressure, thus helping to control blood pressure more effectively. It is particularly suitable for patients with hypertension who do not achieve sufficient effects with monotherapy. This treatment helps in the prevention of complications related to hypertension. Therefore, it is used to maintain stable blood pressure in patients with essential hypertension.
This drug is to be taken once daily with or without food, along with water. It is advisable to take it at the same time daily if possible (e.g., in the morning). The recommended dosing is as follows: - 5/20/12.5mg: Administered to patients whose blood pressure is not appropriately controlled with Amlodipine/Olmesartan Medoxomil combination therapy of 5/20mg. - 5/40/12.5mg: Administered to patients whose blood pressure is not controlled with Amlodipine/Olmesartan Medoxomil combination therapy of 5/40mg.
The safety and efficacy of this drug in pediatric patients under 18 years of age have not been established, therefore its use is not recommended.
This medication may cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy; therefore, it must be discontinued immediately if pregnancy is confirmed. Patients with known allergies or hypersensitivity to this drug or any of its components should not take it. Women who are pregnant or breastfeeding should not take this medication as it may pose risks to the fetus, especially during pregnancy. Patients with severe hypotension, severe aortic stenosis, unstable heart failure after acute myocardial infarction, or severe kidney or liver disease should also avoid this medication. Patients with reduced blood volume or salt may experience symptoms of hypotension during the initial phase of this medication, so they should be closely monitored. This medication may affect kidney function; therefore, patients with kidney disease or those who have undergone kidney transplantation must consult a doctor before taking it. Patients with liver disease or impaired liver function should also exercise caution when taking this medication. This medication lowers blood pressure and may cause dizziness or lightheadedness; thus, caution should be taken when driving or operating hazardous machinery. During the course of this medication, electrolyte levels and kidney function should be regularly checked to ensure there are no abnormalities. This drug may interact with other antihypertensive drugs, diuretics, lithium, etc.; therefore, it is essential to inform the doctor of any other medications being taken. The component Hydrochlorothiazide may increase sensitivity to sunlight; therefore, care should be taken regarding UV protection while taking it, and any skin issues should be reported to a doctor. Overdose of this medication may lead to hypotension, abnormal heart rate, electrolyte imbalance, etc.; hence, the prescribed dosage must be adhered to, and any unusual symptoms should be reported to healthcare professionals immediately. The safety and efficacy of this drug in children and adolescents under 18 years of age have not been established, so its use is not recommended. Elderly patients may have decreased kidney and liver function; thus, starting with a lower dose and taking with caution is advised. This medication should be stored away from moisture, heat, and direct sunlight, and kept out of reach of children.
Urticaria, severe swelling (edema), tightness in the chest, difficulty breathing, cold sweat, pallor, severe rash with fever, blisters, skin peeling, pain in oral/eye mucosa, shortness of breath or difficulty breathing, asthma attacks, respiratory issues with cough + fever, yellowing of skin or eyes (jaundice), severe lethargy, sudden and very severe headaches, thunderclap headaches, seizures, altered consciousness, vision disturbances, paralysis, urination changes.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and moisture and should be stored in a tightly sealed container. It is best to maintain a storage temperature between 1 to 30 degrees Celsius at room temperature. This will help safely retain the medication’s efficacy.
White and orange round film-coated tablet
30 tablets/PTP [10 tablets/PTP × 3]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Olmesartan Medoxomil 20mg · Amlodipine Besylate 6.944mg +1 more
Tablet · Prescription medication · Combination
Aprogen Biologics Co., Ltd.
CombinationOlmesartan Medoxomil 40mg · Amlodipine Besylate 6.944mg +1 more
Tablet · Prescription medication · Combination
Hanmi Daiichi Sankyo Co., Ltd.
CombinationOlmesartan Medoxomil 40mg · Amlodipine Besylate 13.888mg +1 more
Tablet · Prescription medication · Combination
Daicel Corporation (Co., Ltd.)
CombinationOlmesartan Medoxomil 20mg · Amlodipine Besylate 6.944mg +1 more
Tablet · Prescription medication · Combination
HanKook Daiichi Sankyo Co., Ltd.
Olmesartan Medoxomil · Amlodipine Besylate +1 more
Prescription medication · Combination
SYNEX Co., Ltd.
Olmesartan Medoxomil · Amlodipine Besylate +1 more
Prescription medication · Combination
SYNEX Co., Ltd.
Olmesartan Medoxomil · Amlodipine Besylate +1 more
Prescription medication · Combination
SYNEX Co., Ltd.
CombinationAmlodipine Besylate 6.944mg · Olmesartan Medoxomil 20mg +1 more
Tablet · Prescription medication · Combination
JW Pharmaceutical Corporation
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.